PEPTIDE

CJC 1295 (with/without DAC)

CJC-1295 is a stabilized synthetic analog of human growth hormone-releasing hormone (GHRH), available in two research formulations:

CJC-1295 (No DAC / Mod GRF 1-29): Short-acting, produces physiological pulsatile growth hormone (GH) release mimicking natural endogenous secretion
CJC-1295 (With DAC): Long-acting, using Drug Affinity Complex (DAC) albumin-binding technology to deliver sustained GH elevation for 6–8 days per dose.
Both are used to study GH secretion, body composition modulation, muscle anabolism, fat metabolism, and exercise recovery.

CJC-1295 is an enzyme-stabilized synthetic analog of human growth hormone-releasing hormone (GHRH), designed to selectively stimulate growth hormone (GH) secretion from pituitary somatotroph cells. It is manufactured in two distinct, research-optimized formulations:

1. CJC-1295 Without DAC (Mod GRF 1-29)

A 29-amino acid modified GHRH analog with a ~30-minute circulating half-life
Produces physiological pulsatile GH release that replicates natural endogenous GH secretion patterns, preserving long-term GH receptor sensitivity
The gold-standard short-acting GHRH analog for research, widely used in synergistic stacks with GHRP peptides (e.g., Ipamorelin) to amplify GH secretion
Core research applications: body composition studies (muscle anabolism, fat loss), exercise recovery models, and physiological GH regulation research

2. CJC-1295 With DAC

Incorporates proprietary Drug Affinity Complex (DAC) technology: a maleimido-lysine linker that covalently binds to serum albumin, extending the peptide’s functional half-life to 6–8 days
Delivers sustained, steady GH elevation over multiple days from a single dose, eliminating frequent dosing requirements
Core research applications: long-term GH modulation studies, chronic body composition intervention models, and extended-duration GH secretion research

Both formulations are produced to ≥99% purity, sterile-filtered, and lyophilized for long-term storage stability.

For laboratory research use only; not intended for human or veterinary administration.

Research use only: This material is supplied for laboratory research and documentation workflows only. It is not intended for human consumption, diagnostic use, therapeutic use, veterinary use or clinical application.

Hytan procurement and documentation support

For CJC 1295 (with/without DAC), Hytan Peptides can support research-use sourcing review with available batch COA, vial labeling, product identity notes, storage documentation and wholesale quantity discussion. Product-specific CAS, sequence, molecular weight or method details should be confirmed against the current batch document before procurement decisions.

COA review: request batch-specific purity and identity references where available.
Wholesale planning: confirm vial strength, quantity, lead time, packing and destination requirements.
Compliance: research-use wording should remain clear in quote, invoice and receiving records.

Manufacturing Capability

Controlled production for consistent research peptide supply

Hytan Peptides supports wholesale research peptide orders with organized production workflow, clean handling, standardized filling, labeling and batch-level documentation. From material preparation to final review, each step is managed to support consistent appearance, traceable COA records and dependable supply coordination.

This production overview helps laboratories, distributors and qualified research buyers understand how Hytan Peptides approaches quality-focused peptide manufacturing, packaging and order readiness.